Synthesis and In Vitro Activity of Polyhalogenated 2-phenylbenzimidazoles as a New Class of anti-MRSA and Anti-VRE Agents

Chemical Biology & Drug Design
Hakan GökerCan Özgür Yalcin

Abstract

A series of novel polyhalogenated 2-phenylbenzimidazoles have been synthesized and evaluated for in vitro antistaphylococcal activity against drug-resistant bacterial strains (methicillin-resistant Staphylococcus aureus, and vancomycin-resistant Enterococcus faecium. Certain compounds inhibit bacterial growth perfectly. 11 was active than vancomycin (0.78 μg/mL) with the lowest MIC values with 0.19 μg/mL against methicillin-resistant Staphylococcus aureus, 8 and 35 exhibited best inhibitory activity against vancomycin-resistant Enterococcus faecium (1.56 μg/mL). The mechanism of action for this class of compounds appears to be different than clinically used antibiotics. These polyhalogenated benzimidazoles have potential for further investigation as a new class of potent anti-methicillin-resistant Staphylococcus aureus and anti-vancomycin-resistant Enterococcus faecium agents.

References

Jul 1, 1997·The Journal of Antimicrobial Chemotherapy·K HiramatsuF C Tenover
May 4, 2004·Chembiochem : a European Journal of Chemical Biology·Grégori GerebtzoffAnna Seelig
Sep 15, 2004·International Journal of Antimicrobial Agents·F M E Wagenlehner, K G Naber
Jun 7, 2005·Expert Opinion on Therapeutic Targets·John F Barrett
Aug 19, 2005·Expert Review of Anti-infective Therapy·André Bryskier
Nov 2, 2005·European Journal of Medicinal Chemistry·Gabriel Navarrete-VázquezFrancisco Hernández-Luis
Nov 21, 2007·European Journal of Medicinal Chemistry·Seçkin OzdenHakan Göker
Jul 1, 2008·The Biochemical Journal·Mario A PaganoLorenzo A Pinna
Apr 11, 2009·Journal of Medicinal Chemistry·Yunxiang LuWeiliang Zhu
Sep 15, 2009·Bioorganic & Medicinal Chemistry·Alessandra GianoncelliLorenzo A Pinna
Mar 10, 2010·Current Drug Targets·Marcelo Zaldini HernandesAna Cristina Lima Leite
May 1, 2010·European Journal of Medicinal Chemistry·Francisco Hernández-LuisLilián Yépez-Mulia
Nov 27, 2010·The Lancet Infectious Diseases·Ian M Gould
Feb 1, 2011·Chemistry & Biology·Oleg FedorovStefan Knapp
Mar 24, 2012·Current Opinion in Virology·Francisco M Marty, Michael Boeckh
Apr 3, 2012·Expert Opinion on Drug Discovery·Yunxiang LuWeiliang Zhu
Apr 14, 2012·Chemical Biology & Drug Design·Hacer KarataşHakan Göker
Dec 12, 2012·Protein Science : a Publication of the Protein Society·Matthew R ScholfieldP Shing Ho
Apr 9, 2014·Archives of Toxicology·Aylin UstündağGisela H Degen

Citations

Jun 30, 2017·Organic & Biomolecular Chemistry·Caixia XieChen Ma
Jan 3, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Karolina WitekClaus Jacob

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.